| Disorder | Symbol(s) | OMIM | Location |
| Bardet-Biedl syndrome 13, 209900 (3) | MKS1, MKS, BBS13 | 609883 |
17q23 |
| Bardet-Biedl syndrome 14, 209900 (3) | CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14 | 610142 |
12q21.3 |
| Bardet-Biedl syndrome 2, 209900 (3) | BBS2 | 606151 |
16q21 |
| Bardet-Biedl syndrome 3, 209900 (3) | ARL6, BBS3 | 608845 |
3p12-q13 |
| Bardet-Biedl syndrome 4, 209900 (3) | BBS4 | 600374 |
15q22.3-q23 |
| Bardet-Biedl syndrome 5, 209900 (3) | BBS5 | 603650 |
2q31 |
| Bardet-Biedl syndrome 6, 209900 (3) | MKKS, HMCS, KMS, MKS, BBS6 | 604896 |
20p12 |
| Bardet-Biedl syndrome 7, 209900 (3) | BBS7 | 607590 |
4q27 |
| Bardet-Biedl syndrome 8, 209900 (3) | TTC8, BBS8 | 608132 |
14q32.1 |
| Bardet-Biedl syndrome 9, 209900 (3) | PTHB1, BBS9 | 607968 |
7p14 |
| Bare lymphocyte syndrome, type I, 604571 (3) | TAP1, ABCB2, TAP1, RING4, PSF1 | 170260 |
6p21.3 |
| Bare lymphocyte syndrome, type I, 604571 (3) | TAPBP, TPSN | 601962 |
6p21.3 |
| Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3) | TAP2, ABCB3, PSF2, RING11 | 170261 |
6p21.3 |
| Bare lymphocyte syndrome, type II, complementation group A, 209920 (3) | MHC2TA, C2TA | 600005 |
16p13 |
| Bare lymphocyte syndrome, type II, complementation group C, 209920 (3) | RFX5 | 601863 |
1q21.1-q21.3 |
| Bare lymphocyte syndrome, type II, complementation group D, 209920 (3) | RFXAP | 601861 |
13q14 |
| Bare lymphocyte syndrome, type II, complementation group E, 209920 (3) | RFX5 | 601863 |
1q21.1-q21.3 |
| Bart-Pumphrey syndrome, 149200 (3) | GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID | 121011 |
13q11-q12 |
| Barth syndrome, 302060 (3) | TAZ, EFE2, BTHS, CMD3A, LVNCX | 300394 |
Xq28 |
| Bartter syndrome, type 1, 601678 (3) | SLC12A1, NKCC2 | 600839 |
15q15-q21.1 |
